Tag Archives: NASDAQ:AMPH

The President and General Counsel of Amphastar Pharmaceuticals (NASDAQ: AMPH) is Selling Shares

Today, the President and General Counsel of Amphastar Pharmaceuticals (AMPH – Research Report), Jason Shandell, sold shares of AMPH for $114.5K. Following Jason Shandell’s last AMPH Sell transaction on June 01, 2017, the stock climbed by 6.8%. See today’s analyst

Jefferies Believes Amphastar Pharmaceuticals (NASDAQ: AMPH) Won’t Stop Here

Jefferies analyst David Steinberg reiterated a Buy rating on Amphastar Pharmaceuticals (AMPH – Research Report) on November 9 and set a price target of $26. The company’s shares opened today at $21.19, close to its 52-week high of $21.65. According

Wells Fargo Believes Amphastar Pharmaceuticals (NASDAQ: AMPH) Won’t Stop Here

In a report released today, David Maris from Wells Fargo maintained a Buy rating on Amphastar Pharmaceuticals (AMPH – Research Report). The company’s shares closed yesterday at $20.71, close to its 52-week high of $20.99. According to TipRanks.com, Maris is

The CEO & Chief Scientific Officer of Amphastar Pharmaceuticals (NASDAQ: AMPH) is Buying Shares

Today, the CEO & Chief Scientific Officer of Amphastar Pharmaceuticals (NASDAQ: AMPH), Jack Zhang, bought shares of AMPH for $642.5K. See today’s analyst top recommended stocks >> Based on Amphastar Pharmaceuticals’ latest earnings report for the quarter ending March 31,

A Director at Amphastar Pharmaceuticals is Exercising Options

Today, a Director at Amphastar Pharmaceuticals, Richard Prins, exercised options of Amphastar Pharmaceuticals for $330.3K. Following Richard Prins’ last AMPH Sell transaction on August 16, 2017, the stock climbed by 4.9%. This is Prins’ first transaction since reporting a Sell

Piper Jaffray Believes Amphastar Pharmaceuticals (NASDAQ: AMPH) Still Has Room to Grow

Piper Jaffray analyst David Amsellem reiterated a Buy rating on Amphastar Pharmaceuticals (NASDAQ: AMPH) yesterday and set a price target of $26. The company’s shares closed yesterday at $18.92, close to its 52-week high of $19.95. According to TipRanks.com, Amsellem